U.S. Pharmaceutical Sales - Q3 2012
The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q3 2012 by units sold
Rank |
Drug |
Units (000) |
|
|
1 |
acetaminophen/hydrocodone Generic |
9,801 |
2.85% |
Stats |
2 |
budesonide Generic |
7,723 |
-17.22% |
Stats |
3 ( 1) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
7,287 |
8.31% |
Stats |
4 ( 1) |
OneTouch
|
6,805 |
2.38% |
Stats |
5 ( 1) |
Nexium AstraZeneca |
6,701 |
4.10% |
Stats |
6 ( 1) |
Cymbalta
|
6,381 |
2.34% |
Stats |
7 ( 1) |
Lantus Sanofi |
6,033 |
4.34% |
Stats |
8 ( 1) |
Advair Diskus GlaxoSmithKline |
5,763 |
2.47% |
Stats |
9 ( 2) |
atorvastatin Generic |
5,531 |
30.20% |
Stats |
10 ( 4) |
Lantus Solostar Sanofi |
4,468 |
14.07% |
Stats |
11 ( 1) |
Crestor AstraZeneca |
4,193 |
3.89% |
Stats |
12 ( 1) |
fentanyl Generic |
4,040 |
0.67% |
Stats |
13 ( 2) |
enoxaparin Generic |
3,738 |
-2.35% |
Stats |
14 ( 3) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,471 |
1.34% |
Stats |
15 ( 1) |
AndroGel AbbVie Inc. |
3,352 |
-4.66% |
Stats |
16 ( 3) |
Novolog Novo Nordisk |
3,113 |
3.53% |
Stats |
17 ( 3) |
Levemir Novo Nordisk |
2,957 |
4.30% |
Stats |
18 ( 4) |
NovoLog FlexPen Novo Nordisk |
2,742 |
3.28% |
Stats |
19 ( 16) |
Singulair Merck |
2,657 |
-62.80% |
Stats |
20 ( 5) |
Humalog Eli Lilly and Company |
2,552 |
3.53% |
Stats |
21 ( 3) |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,515 |
0.80% |
Stats |
22 ( 1) |
metoprolol Generic |
2,483 |
-2.63% |
Stats |
23 ( 2) |
Nasonex Merck |
2,468 |
-10.19% |
Stats |
24 ( 2) |
Synthroid AbbVie Inc. |
2,455 |
4.96% |
Stats |
25 ( 2) |
Januvia Merck |
2,325 |
1.17% |
Stats |
26 ( 11) |
escitalopram Generic |
2,199 |
27.33% |
Stats |
27 ( 2) |
Namenda Allergan plc |
2,087 |
4.61% |
Stats |
28 ( 4) |
Symbicort AstraZeneca |
2,048 |
6.95% |
Stats |
29 ( 1) |
Lyrica
|
2,024 |
2.12% |
Stats |
30 ( 3) |
Suboxone
|
2,001 |
4.93% |
Stats |
31 |
Zetia Merck |
1,952 |
1.72% |
Stats |
32 ( 4) |
Diovan Novartis Pharmaceuticals Corporation |
1,946 |
-4.00% |
Stats |
33 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
1,928 |
1.26% |
Stats |
34 ( 1) |
Flovent HFA GlaxoSmithKline |
1,737 |
-1.59% |
Stats |
35 ( 4) |
Lidoderm Endo Pharmaceuticals Inc. |
1,659 |
4.21% |
Stats |
36 ( 4) |
Lovaza GlaxoSmithKline |
1,648 |
6.39% |
Stats |
37 ( 1) |
Remicade Janssen Pharmaceuticals, Inc. |
1,621 |
1.76% |
Stats |
38 ( 3) |
Benicar Daiichi Sankyo |
1,469 |
1.38% |
Stats |
39 ( 5) |
Restasis Allergan plc |
1,442 |
8.67% |
Stats |
40 ( 3) |
Dexilant Takeda Pharmaceutical Company Limited |
1,428 |
3.33% |
Stats |
41 ( 5) |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,405 |
16.21% |
Stats |
42 ( 3) |
OxyContin Purdue Pharma LP |
1,253 |
0.16% |
Stats |
43 ( 4) |
Vytorin Merck |
1,176 |
-2.41% |
Stats |
44 ( 4) |
VESIcare Astellas Pharma US, Inc. |
1,037 |
2.37% |
Stats |
45 ( 4) |
Celebrex
|
1,036 |
3.70% |
Stats |
46 ( 4) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
1,028 |
4.58% |
Stats |
47 ( 5) |
Niaspan AbbVie Inc. |
1,006 |
6.23% |
Stats |
48 ( 5) |
Enbrel Amgen Inc. |
995 |
13.33% |
Stats |
49 ( 2) |
Janumet Merck |
983 |
0.92% |
Stats |
50 ( 4) |
Evista
|
946 |
9.62% |
Stats |
51 ( 15) |
Actos Takeda Pharmaceutical Company Limited |
929 |
-46.64% |
Stats |
52 ( ) |
EpiPen 2-Pak
|
892 |
n/a |
Stats |
53 ( 2) |
TriCor AbbVie Inc. |
851 |
6.11% |
Stats |
54 ( 5) |
Cialis Eli Lilly and Company |
750 |
7.76% |
Stats |
55 ( 1) |
Vyvanse Takeda Pharmaceutical Company Limited |
749 |
-2.60% |
Stats |
56 ( 1) |
Aciphex Eisai Inc. |
743 |
-2.37% |
Stats |
57 ( 1) |
methylphenidate Generic |
715 |
-2.19% |
Stats |
58 ( 2) |
amphetamine/dextroamphetamine Generic |
684 |
3.95% |
Stats |
59 ( 3) |
Humira AbbVie Inc. |
640 |
7.56% |
Stats |
60 ( 5) |
Rebif EMD Serono, Inc. |
637 |
11.36% |
Stats |
61 |
Epogen Amgen Inc. |
607 |
-3.04% |
Stats |
62 ( 2) |
Truvada Gilead Sciences, Inc. |
577 |
0.52% |
Stats |
63 |
Rituxan Genentech, Inc. |
557 |
-3.30% |
Stats |
64 ( 5) |
Victoza Novo Nordisk |
516 |
18.08% |
Stats |
65 ( 23) |
Lipitor
|
513 |
-63.30% |
Stats |
66 |
Atripla Gilead Sciences, Inc. |
475 |
-0.42% |
Stats |
67 |
Avastin Genentech, Inc. |
472 |
-0.84% |
Stats |
68 |
Viagra
|
455 |
1.56% |
Stats |
69 ( 1) |
Seroquel XR AstraZeneca |
430 |
-0.46% |
Stats |
70 ( 1) |
modafinil Generic |
395 |
-0.25% |
Stats |
71 ( 8) |
Varivax Merck |
385 |
33.68% |
Stats |
72 ( 2) |
Lunesta Sunovion Pharmaceuticals Inc. |
342 |
2.40% |
Stats |
73 ( 2) |
Orencia Bristol-Myers Squibb Company |
335 |
1.52% |
Stats |
74 ( 2) |
Adderall XR Takeda Pharmaceutical Company Limited |
333 |
-11.90% |
Stats |
75 ( 2) |
Neulasta Amgen Inc. |
331 |
-1.19% |
Stats |
76 ( 2) |
Renvela Sanofi |
316 |
7.48% |
Stats |
77 ( ) |
Sensipar Amgen Inc. |
306 |
n/a |
Stats |
78 ( ) |
Xolair
|
292 |
n/a |
Stats |
79 ( 3) |
Procrit Janssen Pharmaceuticals, Inc. |
292 |
-7.59% |
Stats |
80 ( 2) |
Reyataz Bristol-Myers Squibb Company |
276 |
-1.08% |
Stats |
81 ( 1) |
Aranesp Amgen Inc. |
272 |
-3.55% |
Stats |
82 ( 2) |
Isentress Merck |
261 |
2.76% |
Stats |
83 ( 3) |
Copaxone Teva Pharmaceuticals USA, Inc. |
247 |
9.78% |
Stats |
84 ( ) |
Gardasil Merck |
228 |
n/a |
Stats |
85 ( 2) |
Prezista Janssen Pharmaceuticals, Inc. |
221 |
0.91% |
Stats |
86 ( 2) |
Lucentis Genentech, Inc. |
213 |
n/a |
Stats |
87 ( ) |
Zostavax Merck |
201 |
n/a |
Stats |
88 ( 1) |
Alimta Eli Lilly and Company |
182 |
-2.67% |
Stats |
89 ( 1) |
Neupogen Amgen Inc. |
177 |
n/a |
Stats |
90 ( 2) |
Herceptin Genentech, Inc. |
162 |
-0.61% |
Stats |
91 |
Prevnar 13 Pfizer Inc. |
158 |
-5.39% |
Stats |
92 ( 2) |
Zyvox Pfizer Inc. |
129 |
-8.51% |
Stats |
93 ( 12) |
Eloxatin Sanofi |
128 |
-54.45% |
Stats |
94 ( 1) |
Avonex Biogen |
123 |
-6.82% |
Stats |
95 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
92 |
9.52% |
Stats |
96 ( 1) |
Xeloda Genentech, Inc. |
65 |
-1.52% |
Stats |
97 ( 1) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
63 |
6.78% |
Stats |
98 ( 1) |
Gilenya Novartis Pharmaceuticals Corporation |
55 |
12.24% |
Stats |
99 ( ) |
Stelara Janssen Pharmaceuticals, Inc. |
22 |
n/a |
Stats |
100 |
Incivek Vertex Pharmaceuticals Incorporated |
18 |
-18.18% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.